These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18088553)

  • 41. BIRMA-K3, a new monoclonal antibody for CD34 immunophenotyping and stem and progenitor cell assay.
    Höffkes HG; Lowe JA; Pedersen RO; Schmidkte G; McDonald DF
    J Hematother; 1996 Jun; 5(3):261-70. PubMed ID: 8817393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of CD34 epitopes in AML.
    Sutherland R; Keeney M; Gratama JW
    Haematologica; 2003 Jun; 88(6):ELT22; author reply ELT23. PubMed ID: 12801861
    [No Abstract]   [Full Text] [Related]  

  • 43. [Early stages of CD34+ differentiation during radiation exposure].
    Bieliaieva NV
    Lik Sprava; 2006 Jun; (4):20-6. PubMed ID: 17100234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [General immunologic reactivity of patients with spinal injuies and lesions of the spinal cord].
    Kaplan AE; Virozub ID; Ioannesian BI
    Vopr Neirokhir; 1968; 32(4):23-6. PubMed ID: 5726093
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on post-transfusion isoimmunization in patients with complete injuries of the spinal cord].
    Maczyńska-Rusiniak B; Tesserowicz J
    Pol Tyg Lek; 1967 Dec; 22(49):1877-9. PubMed ID: 5595160
    [No Abstract]   [Full Text] [Related]  

  • 46. CD34 expression does not correlate with immunophenotypic stem cell or progenitor content in human cord blood products.
    Mantri S; Reinisch A; Dejene BT; Lyell DJ; DiGiusto DL; Agarwal-Hashmi R; Majeti R; Weinberg KI; Porteus MH
    Blood Adv; 2020 Nov; 4(21):5357-5361. PubMed ID: 33136125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies.
    Blümcke I; Giencke K; Wardelmann E; Beyenburg S; Kral T; Sarioglu N; Pietsch T; Wolf HK; Schramm J; Elger CE; Wiestler OD
    Acta Neuropathol; 1999 May; 97(5):481-90. PubMed ID: 10334485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of circulating CD34+ stem cells in peripheral venous blood in patients with varying degrees of periodontal disease.
    Aleksandrowicz P; Kotuła LZ; Grabowska K; Krakowiak RL; Kusa-Podkańska M; Agier J; Gorący A; Kądziołka KE; Kocki J; Wysokińska-Miszczuk J
    Ann Agric Environ Med; 2021 Sep; 28(3):516-520. PubMed ID: 34558278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF.
    Janowski M; Walczak P; Kropiwnicki T; Jurkiewicz E; Domanska-Janik K; Bulte JW; Lukomska B; Roszkowski M
    PLoS One; 2014; 9(2):e97631. PubMed ID: 24919061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection.
    Sonoda Y
    J Autoimmun; 2008 May; 30(3):136-44. PubMed ID: 18243660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
    Otto M; Chen X; Martin WJ; Leung W; Knowles J; Holladay M; Houston J; Handgretinger R; Barfield RC
    Stem Cells; 2007 Feb; 25(2):537-42. PubMed ID: 17023516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunophenotypic peculiarities of mobilized stem (CD34+) cells in blood from patients with severe spinal cord injury.
    Tupitsyn NN; Yaryghin VN; Bryukhovetskiy AS; Grivtsova LY; Mentkevich GL; Dolgopolov IS; Zaitsev AY; Davydov MI
    J Biol Regul Homeost Agents; 2006; 20(1-2):36-40. PubMed ID: 18088553
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.